This platform is exclusively for licensed businesses, trade buyers, and qualified professionals operating in regulated cannabis markets. It is not intended for consumers or the general public.
By entering you confirm compliance with applicable laws in your jurisdiction.
Cannvera EU · B2B only · Not for consumer use.
Australia is one of the world's most established medical cannabis markets, with a sophisticated regulatory framework and strong pharmacy demand. Cannvera has supplied Australian buyers and understands the TGA documentation requirements. Australia's market is characterized by high quality standards and strong price tolerance for premium, fully documented product.
Australian medical cannabis is regulated by the Therapeutic Goods Administration (TGA). All imported cannabis must meet TGA standards and be listed on the Australian Register of Therapeutic Goods (ARTG) or imported under the Special Access Scheme (SAS). GMP certification is mandatory. The Australian market has strict cannabinoid profile and residual solvent standards.
Obtain TGA Special Access Scheme (SAS) authorization or ARTG listing
Verify TGA-recognized GMP certification
Prepare full TGA documentation package
Arrange logistics via established freight routes (Europe → Australia)
Australian Customs and Border Protection clearance
Delivery to licensed Australian importer or distributor
Cannvera has active supply relationships in Australia. The Australian market demands premium documentation and consistent quality — areas where Cannvera's multi-origin sourcing and EU GMP processing network excel.
Cannvera's team can advise on documentation requirements and connect you with the right licensed importers in Australia.
Submit Compliance Inquiry